| Notable relationship between the level of tumor marker TPS in serum and survival in breast cancer. | |
| | |
MedLine Citation:
|
PMID: 8687149 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Tissue Polypeptide Specific antigen (TPS) in serum was measured once during the follow-up of 200 breast cancer patients and compared with survival. Within 12 months, patients with normal TPS (< 80 U/L) exhibited a 3% death rate (3/96), which was undistinguishable from the mortality of normal females of corresponding age. Patients with moderate TPS (80-400 U/L) suffered 19% death (14/72), and patients with high TPS (> 400 U/L) 72% death (23/32). The relative risk (RR) of death within 6 months was 1 with normal TPS, 8 with moderate TPS, and 48 with high TPS. RR for 12 months was 1, 6, and 23, respectively. Serum TPS at admission had a significant predictive value with regard to survival up to 12 months. |
| | |
Authors:
|
K Bremer; G Eklund; B Björklund |
Related Documents
:
|
9776149 - Early experience of endoscopic extirpation of benign breast tumors via an extra-mammary... 23204799 - Astigmatic changes after horizontal rectus muscle surgery in intermittent exotropia. 12271279 - Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of... 19076629 - Cross technique: chemical reconstruction of skin scars method. 9030149 - Abdominal-wall recovery following tram flap: a functional outcome study. 19924469 - Augmentation mastopexy in muscle-splitting biplane: outcome of first 44 consecutive cas... 8838729 - Arthroscopic assisted rotator cuff repair: results using a mini-open deltoid splitting ... 9458249 - Thigh pain following tourniquet application in simultaneous bilateral total knee replac... 20151839 - Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the tre... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Anticancer research Volume: 16 ISSN: 0250-7005 ISO Abbreviation: Anticancer Res. Publication Date: 1996 Mar-Apr |
Date Detail:
|
Created Date: 1996-08-21 Completed Date: 1996-08-21 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8102988 Medline TA: Anticancer Res Country: GREECE |
Other Details:
|
Languages: eng Pagination: 905-9 Citation Subset: IM |
Affiliation:
|
Clinic of Hematology and Oncology, Bochum, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Breast Neoplasms
/
blood*,
mortality* Female Humans Peptides / blood* Prognosis Time Factors Tumor Markers, Biological / blood* |
| Chemical | |
Reg. No./Substance:
|
0/Peptides; 0/Tumor Markers, Biological; 0/tissue polypeptide specific antigen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuc...
Next Document: Adjuvant treatment for breast cancer in the elderly.